- Research Article
- 10.1016/j.imlet.2025.107122
Lenvatinib-resistant liver cancer-derived HSP90α-containing extracellular vesicles enhance drug resistance via macrophage CXCL8 secretion.
- Apr 01, 2026
- Immunology letters
- Xin-Wei Xu + 9 more +9
Publications from 2021 to 2026
Showing 10 of 435 papers
Lenvatinib-resistant liver cancer-derived HSP90α-containing extracellular vesicles enhance drug resistance via macrophage CXCL8 secretion.
Global temporal trends and projections of rheumatoid arthritis incidence among women of childbearing age: age-period-cohort analysis 2021.
This study aimed to analyze the trends and disease burden of rheumatoid arthritis (RA) among women of childbearing age (15-49years) globally from 1992 to 2021, revealing temporal dynamics and regional disparities to provide scientific evidence for epidemiological research and public health policies. Based on data from the Global Burden of Disease Study (GBD 2021), this study employed the age-period-cohort (APC) model to analyze trends across different age groups, periods, and birth cohorts. Additionally, a Bayesian model was used to project the disease burden from 2022 to 2040. From 1992 to 2021, the global number of RA cases increased from approximately 202,000 to 327,000, with the age-standardized incidence rate (ASIR) rising from 15.34 to 16.57 per 100,000, representing an annual net drift of 0.42%. High Socio-demographic Index (SDI) regions had the highest incidence (22.77/100,000 in 2021) but showed stable trends, while low SDI regions had the lowest incidence (7.84/100,000 in 2021) but exhibited faster growth (annual net drift of 0.75%). Middle-low SDI regions experienced the fastest growth in incidence (annual net drift of 1.07%). RA risk increased with age, peaking in the 45-49 age group. India saw a significant rise in RA cases, while China showed a declining trend. By 2040, the number of RA cases was projected to reach approximately 378000, with global ASIR expected to show moderate growth but persistent regional disparities. This study revealed the complex epidemiological landscape of RA among women of childbearing age, with global incidence continuing to rise, particularly in low- and middle-income regions. It emphasized the importance of region-specific prevention and management strategies to address the growing burden of RA. Key Points • A significant increase in RA cases globally, from approximately 202,000 in 1992 to 327,000 in 2021, with an age-standardized incidence rate (ASIR) rising from 15.34 to 16.57 per 100,000. • Regional disparities in RA burden, with high Socio-demographic Index (SDI) regions showing the highest incidence (22.77/100,000 in 2021) but stable trends, while low and middle-low SDI regions exhibit the fastest growth (annual net drift of 0.75% and 1.07%, respectively). • Age-specific patterns, with RA risk peaking in the 45-49 age group.Projections indicating a continued rise in RA cases, reaching approximately 378000 by 2040, with persistent regional disparities. • This study highlights the complex epidemiological landscape of RA among women of childbearing age, emphasizing the need for region-specific prevention and management strategies to address the growing burden, particularly in low- and middle-income regions.
Read more11MO First disclosure of efficacy and safety data for YL202/BNT326 (HER3 ADC) from a phase II trial in patients (pts) with non-small cell lung cancer (NSCLC)
Shuxuening injection for acute ischemic stroke: Efficacy and safety - a randomized, double-blind, placebo controlled, multi-center clinical trial.
All-inside endoscopic and minimally invasive modified Bunnell suture yield favourable outcomes in acute midsubstance Achilles tendon ruptures: a comparative study.
This study compared the clinical outcomes of the all-inside endoscopic and the minimally invasive modified Bunnell suture configurations for the management of acute midsubstance Achilles tendon ruptures (AMATR). A retrospective analysis was conducted on 63 AMATR patients (54 men and 9 women, with a mean age of 39.84 ± 10.40 years (range, 21-62 years). All patients underwent Achilles tendon repair using the modified Bunnell suture configuration using the all-inside endoscopic repair (n = 31) or a minimally invasive repair (n = 32). The primary endpoint was postoperative functional outcome, assessed using the American Orthopaedic Foot and Ankle Society (AOFAS) score and the Achilles Tendon Total Rupture Score (ATRS) at 6, 12, and 24 months. Secondary endpoints included perioperative and short-term recovery parameters, including operative time, incision length, postoperative pain assessed by the Visual Analog Scale (VAS) on postoperative days 1 and 3, wound complications, and time to return to work and sports activities. There were no intraoperative complications, and all patients in the endoscopic group achieved primary wound healing. At the 6-, 12-, and 24-month follow-up, both groups demonstrated significant improvement in AOFAS and ATRS scores over time, with no significant differences between groups. Regarding secondary endpoints, the all-inside endoscopic group had a significantly longer operative time but a significantly shorter incision length compared with the minimally invasive group (p < 0.05). VAS pain scores on postoperative days 1 and 3 were significantly lower in the endoscopic group (p < 0.05). No wound infections occurred in the endoscopic group, whereas three superficial infections were observed in the minimally invasive group; however, the difference was not statistically significant. Patients in the endoscopic group returned to work one week earlier (p < 0.05), while the time to return to sports was comparable between groups. Both the all-inside endoscopic and the minimally invasive modified Bunnell suture configurations provide reliable repair for AMATR and support a successful return to occupational and athletic activity. While the all-inside endoscopic procedure was associated with a longer operative time, it offered advantages in terms of reduced early postoperative pain, smaller incisions, and earlier return to work, without compromising functional recovery at the 2-year follow-up.
Read morePDCA Cycle-Driven Whole-Chain Optimization of the Pre-Prescription Audit System: A Multidimensional Approach from Pharmacist Competency Development to Dynamic Rule Database Management
Comparison of Short-Term Efficacy of Single-port Endoscopic Discectomy and Unilateral Biportal Endoscopic Discectomy in the Treatment of L5/S1 Lumbar Disc Herniation at Michigan State University Grade 2
Abstract Background and Objective Single-port endoscopic (open surgical excision [OSE]) discectomy and unilateral biportal endoscopic (UBE) discectomy have demonstrated effective therapeutic outcomes in lumbar disc herniation (LDH) treatment. However, there is a lack of clear guidelines for selecting surgical techniques for LDH at Michigan State University (MSU) grade 2. This study aimed to compare the clinical efficacy and imaging data of OSE and UBE in treating L5/S1 LDH at MSU grade 2. Methods This retrospective cohort study enrolled patients with L5/S1 LDH who were admitted between September 2022 and July 2024. Patients were stratified into OSE (n = 97) and UBE (n = 119) groups according to the surgical technique performed. Each group was further stratified into two subgroups based on the MSU classification of LDH (types 2B and 2C). All patients were followed for a minimum of one year. Perioperative parameters, serum levels of prostaglandin E2 (PGE2) and transthyretin (TTR), visual analog scale (VAS) score, Oswestry Disability Index (ODI), postoperative complication rate, recurrence rate, and modified MacNab criteria at the final follow-up were recorded and compared between groups to assess clinical efficacy. Surgical outcomes were further evaluated using radiological parameters, including bone loss volume (BLV), disc height index (DHI), lumbar range of motion (ROM), sagittal translation (ST), and paraspinal muscle relative cross-sectional area (RCSA). Results No significant difference was observed in the operation time and hospital stay between the two groups (P > 0.05). Incision length, intraoperative blood loss, and number of intraoperative fluoroscopy exposures were significantly lower in the OSE group than in the UBE group (P < 0.05). During a minimum of 1 year of postoperative follow-up, no statistically significant difference was observed in the VAS scores of the waist and legs and ODI at any assessed time point between the two groups (P > 0.05). However, the VAS scores of incision-related pain in the OSE group were lower than those in the UBE group on days 1 and 3 postoperatively (P < 0.05). No significant difference was observed between the two groups in complication rates, recurrence rates, modified MacNab scores, DHI, ROM, ST, erector spinae RCSA, or psoas major RCSA within 1 year postoperatively (P > 0.05). However, the OSE group demonstrated significantly better outcomes than the UBE group with respect to bone loss, serum PGE2, TTR levels, and multifidus RCSA (P < 0.05). Conclusion OSE and UBE can achieve good therapeutic effects in the treatment of grade 2 LDH at the L5/S1 segment in patients with MSU. Compared with UBE, OSE demonstrated advantages, including reduced surgical trauma, less early postoperative incision pain, a lower perioperative inflammatory response, improved preservation of bone structure, and enhanced protection of the multifidus muscle, reflecting higher surgical precision and a more minimally invasive profile. In clinical practice, treatment should be individualized based on the specific conditions of each patient.
Read more238 Tumor Next-Generation Sequencing Completion Rate and Genetic Alterations in Chinese Patients with HR+/HER2− Advanced Breast Cancer from CAPItrue Phase IIIb Trial
Nanotechnology-driven biomaterials for chronic liver diseases: Stage-specific strategies for advanced theranostics.
Highly sensitive separation and characterization of multiple mycotoxins by supercritical fluid chromatography combined with ion mobility quadrupole time-of-flight mass spectrometry.